Biotech

Latest Articles

With trial win, Merck seeks to tackle Sanofi, AZ in RSV

.Three months after revealing that its respiratory syncytial infection (RSV) precautionary antibody ...

Noema ticks off phase 2a Tourette win for ex-Roche molecule

.Noema Pharma has actually scored a stage 2a succeed for its Tourette disorder medication applicant,...

Terray puts together $120M series B to advancement AI-powered molecules

.Terray Therapeutics has actually raked in $120 thousand for a collection B fundraise as the AI-focu...

Kezar declines Concentra buyout that 'undervalues' the biotech

.Kezar Life Sciences has actually come to be the latest biotech to decide that it can do better than...

Wave hails individual RNA editing initially for GSK-partnered possibility

.Wave Lifestyle Sciences has actually taken a step towards confirming a brand-new method, becoming t...

Chinese insulin maker's GLP-1 bests Ozempic in ph. 2

.Mandarin the hormone insulin producer Gan &amp Lee Pharmaceuticals is actually wading into the weig...

Teva adopts biotech attitude as it bends right into ingenious drug progression, director points out

.Amid a reorganization initiative that's breathed new life into combination general as well as cutti...

Eli Lilly introduces 2 brand new research centers in China

.Eli Lilly is broadening its own advancement digs to Beijing, China, opening two proving ground refe...

J &amp J unloads many plans, featuring ph. 2 Alzheimer's job

.Johnson &amp Johnson is unloading a number of systems, with three of the culls occurring in the neu...

New biotech goals to enhance thymus Altruism

.Tissue treatment biotech Tolerance Bio has unveiled along with $17.2 thousand and also an objective...

Lundbeck indications $2.5 B check for Longboard as well as its epilepsy med

.After snooping runaway success possibility in Longboard Pharmaceuticals' epilepsy med, brain diseas...

Lilly picks UK for first Entrance Lab in Europe

.Eli Lilly's Gateway Labs is going worldwide, along with the U.K. government declaring today that th...

Jasper dials up dose after colonies reactions reoccur quickly

.Jasper Therapy has mentioned total responses in 10 of the 12 severe colonies clients that got the h...

Transgene's popular cancer cells vaccine fails midphase exam

.Transgene's curative vaccination applicant TG4001 has actually flunked a period 2 sound tumor test....

Upstream swells IPO to $255M as it specifies together with CAMP4

.Upstream Bio possesses puffy its own IPO to $255 thousand as the business joins CAMP4 Therapies tod...

Sanofi flunks MS research, dealing an additional blow to Denali pact

.Sanofi has ceased a phase 2 difficulty of Denali Therapeutics-partnered oditrasertib in various scl...

Turnstone lays off 60%, agitates C-suite to extend money

.Turnstone Biologics is actually reducing its own head count by 60% and also agitating its C-suite t...

Gilead quits on $15M MASH wager after reviewing preclinical data

.In a year that has seen a confirmation as well as a plethora of readouts for metabolic dysfunction-...

Texas biotech centers cancer cells contract, pins wishes on being overweight

.Alaunos Rehabs is axing a contract with Precigen, losing hope licensing civil liberties to a tailor...

Capricor allotments more information for DMD therapy after starting BLA

.Capricor Rehabs is taking a victory tour for their period 2 Duchenne muscular dystrophy (DMD) test....